Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer
Clinical trial NCT04572542 · UNKNOWN
Trial details
- NCT number
- NCT04572542
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.